Volume 28, Number 2—February 2022
Dispatch
SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
Table 2
Results from neutralization testing of serum from persons who were infected with and vaccinated against severe acute respiratory syndrome coronavirus 2, South Korea*
Serum type | PRNT50 GMT (95% CI) |
||
---|---|---|---|
G (D614G) | B.1.619 | B.1.620 | |
Convalescent, n = 7 | 79 (35–179) | 340 (138–830) | 546 (248–1,205) |
Vaccinated, n = 7 | 32 (16–62) | 76 (37–155) | 584 (303–1,125) |
*Test results against G clade (D614G) and B.1.619 and B.1.620 lineages. GMT, geometric mean titer; PRNT50, 50% plaque reduction neutralization test.